Neonatal Risk Factors for Colonization with Extended-Spectrum Beta-Lactamase-Producing Bacteria in the Neonatal Intensive Care Unit

BACKGROUND: Extended-spectrum beta-lactamase (ESBL) production is the most common antimicrobial resistance mechanism in the neonatal intensive care unit (NICU), with colonization and blood stream infections being a major threat to this population. Since 2013, all NICU admissions at our facility were screened twice weekly for ESBL colonization.

OBJECTIVES: To determine independent risk factors for colonization of infants with ESBL-producing bacteria in the NICU.

METHODS: A retrospective case study of ESBL-colonized infants vs. controls (matched by date of birth and gestational age) was conducted in the NICU of Soroka University Medical Center, Israel, between 2013 and 2014. Epidemiological, laboratory, and clinical data were extracted from medical files. Univariable and multivariable analyses were used to assess associations between ESBL colonization and possible clinical risk factors.

RESULTS: Of 639 admissions during the study period, 87 were found to be ESBL-colonized (case infants) and were matched to 87 controls. Five case infants became infected (5.7%) with ESBL strains. Klebsiella pneumoniae was the most common isolated bacteria. The mean time from admission to colonization was 15 days. Univariable analysis showed an association of male gender and highest Apgar score at 1 and 5 minutes with ESBL colonization (P < 0.05). Multivariable analysis yielded only a possible association of higher Apgar score at 1 and 5 minutes (hazard ratio [HR] 1.515, 95% confidence interval [95%CI] 0.993-2.314; HR 1.603, 95%CI 0.958-2.682, respectively) with ESBL colonization.

CONCLUSIONS: Future studies should focus on maternal colonization and possible strategies for preventing vertical transmission of ESBL strains to high-risk neonates.

Medienart:

Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:20

Enthalten in:

The Israel Medical Association journal : IMAJ - 20(2018), 5 vom: 20. Mai, Seite 286-290

Sprache:

Englisch

Beteiligte Personen:

Leikin-Zach, Viktoria [VerfasserIn]
Shany, Eilon [VerfasserIn]
Yitshak-Sade, Maayan [VerfasserIn]
Eshel, Ron [VerfasserIn]
Shafat, Tali [VerfasserIn]
Borer, Avraham [VerfasserIn]
Melamed, Rimma [VerfasserIn]

Themen:

Beta-Lactamases
EC 3.5.2.6
Journal Article

Anmerkungen:

Date Completed 28.05.2019

Date Revised 01.12.2019

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM284082848